Covered recipient · General Payments record
CATHIE-ANN MANCUSO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$3,476.69
- Reported across 256 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.32 | 13 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $141.28 | 8 |
| Lilly USA, LLC | $51.99 | 3 |
| Exact Sciences Corporation | $21.43 | 1 |
| Abbott Laboratories | $16.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.62 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018778875 | CMS |
| Exact Sciences Corporation | $21.43 | 11/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026665469 | CMS |
| Lilly USA, LLC | $16.83 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031304225 | CMS |
| Lilly USA, LLC | $15.70 | 09/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031297011 | CMS |
| Lilly USA, LLC | $19.46 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031314211 | CMS |
| Novo Nordisk Inc | $14.16 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001344131 | CMS |
| Novo Nordisk Inc | $14.17 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001344139 | CMS |
| Novo Nordisk Inc | $20.96 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001331121 | CMS |
| Novo Nordisk Inc | $21.07 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001331130 | CMS |
| Novo Nordisk Inc | $17.15 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001344151 | CMS |
| Novo Nordisk Inc | $17.15 | 09/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001344161 | CMS |
| Novo Nordisk Inc | $18.97 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001331105 | CMS |
| Novo Nordisk Inc | $17.65 | 10/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001331095 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.